Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer
Nicholas F. Brown(University of Pittsburgh), John F. Marshall(Queen Mary University of London)
Cited by 12
Related Papers
Increased β-Oxidation in Muscle Cells Enhances Insulin-stimulated Glucose Metabolism and Protects against Fatty Acid-induced Insulin Resistance Despite Intramyocellular Lipid Accumulation
|Journal of Biological Chemistry|2004|157
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy
|The Journal of Pathology|2019|109